IP Library Granted Patent US 11,866,531
Granted Patent B2
US 11,866,531 · App. 17/031,292 · Granted Jan 9, 2024

Oil-resistant lens material and ophthalmic devices

Inventors: Angela DiCiccio (San Francisco, CA); Daniel Otts (Pleasanton, CA); Stein Kuiper (South San Francisco, CA)
Assignee: Twenty Twenty Therapeutrics LLC
C08F220/24C08F230/08C09K3/1009G02B1/043G02B1/18G02C7/101G02C7/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,866,531
App. No.
17/031,292
Granted
Jan 9, 2024
Kind
B2
Abstract

Lens materials and ophthalmic devices including lens materials that are oxygen permeable and resistant to oil absorption are described. In an embodiment, the lens material includes a copolymer composed of repeating units including: a fluorinated acrylate repeating unit; and a silicon-containing repeating unit, wherein a mass:mass ratio of the fluorinated acrylate repeating unit to the silicon-containing repeating unit is greater than or equal to 2:1.

Claims (42)

1. A lens material for use in an electrowetting ophthalmic device, the lens material comprising a copolymer composed of repeating units including:

a fluorinated acrylate repeating unit; and

a silicon-containing repeating unit,

wherein a mass:mass ratio of the fluorinated acrylate repeating unit to the silicon-containing repeating unit is greater than or equal to 2:1,

wherein the lens material has an oxygen permeability level in a range of about 30 Dk to about 100 Dk.

2. The lens material of claim 1 , wherein the fluorinated acrylate repeating unit has a formula (1):

wherein

R 1 is selected from the group consisting of fluorinated straight-chain alkyl groups, fluorinated branched alkyl groups, fluorinated cyclic alkyl groups, fluorinated aryl groups, and fluorinated alkenyl groups; and

R 2 is selected from the group consisting of H, straight-chain alkyl groups, branched alkyl groups, cyclic alkyl groups, alkenyl groups, and aryl groups.

3. The lens material of claim 2 , wherein the fluorinated acrylate repeating unit is derived from a fluorinated methacrylate monomer selected from the group consisting of a hexafluoroisopropyl methacrylate monomer, a trifluoroethyl methacrylate monomer, and combinations thereof.

4. The lens material of claim 1 , wherein the silicon-containing repeating unit is derived from a monomer selected from the group consisting of a silyl methacrylate monomer, a silyl styrene monomer, and combinations thereof.

5. The lens material of claim 4 , wherein the silicon-containing repeating unit has a formula (2):

wherein

each R 3 is independently selected from the group consisting of straight-chain alkyl groups, branched alkyl groups, cyclic alkyl groups, aryl groups, and alkenyl groups;

R 4 is selected from the group consisting of H, straight-chain alkyl groups, branched alkyl groups, cyclic alkyl groups, alkenyl groups, and aryl groups; and

n is an integer in a range of 1 to 20.

6. The lens material of claim 1 , wherein the silicon-containing repeating unit is 3-[tris(trimethylsiloxy)silyl]propyl methacrylate.

7. The lens material of claim 1 , wherein the mass:mass ratio of the fluorinated acrylate repeating unit to the silicon-containing repeating unit is in a range of about 2:1 to about 100:1.

8. The lens material of claim 1 , further comprising a crosslinking agent.

9. The lens material of claim 8 , wherein the crosslinking agent is selected from the group consisting of butanediol dimethacrylate, ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, propylene glycol dimethacrylate, dipropylene glycol dimethacrylate, allylmethacrylate, vinylmethacrylate, trimethylolpropane trimethacrylate, neopentyl glycol dimethacrylate, and combinations thereof.

10. The lens material of claim 1 , wherein the lens material is configured to absorb less than 1 wt % of an oil after contacting an excess of the oil for 10 days at 37° C.

11. An ophthalmic device comprising:

a lens material comprising a copolymer composed of repeating units including:

a fluorinated acrylate repeating unit; and

a silicon-containing repeating unit,

wherein a mass:mass ratio of the fluorinated acrylate repeating unit to the silicon-containing repeating unit is greater than or equal to 2:1, and

wherein the lens material defines an enclosure encasing an oil,

wherein the lens material has an oxygen permeability level in a range of about 30 Dk to about 100 Dk.

12. The ophthalmic device of claim 11 , wherein the fluorinated acrylate repeating unit has a formula (1):

wherein

R 1 is selected from the group consisting of fluorinated straight-chain alkyl groups, fluorinated branched alkyl groups, fluorinated cyclic alkyl groups, fluorinated aryl groups, and fluorinated alkenyl groups; and

R 2 is selected from the group consisting of H, straight-chain alkyl groups, branched alkyl groups, cyclic alkyl groups, alkenyl groups, and aryl groups.

13. The ophthalmic device of claim 11 , wherein the silicon-containing repeating unit has a formula (2):

wherein

each R 3 is independently selected from the group consisting of straight-chain alkyl groups, branched alkyl groups, cyclic alkyl groups, aryl groups, and alkenyl groups;

R 4 is selected from the group consisting of H, straight-chain alkyl groups, branched alkyl groups, cyclic alkyl groups, alkenyl groups, and aryl groups; and

n is an integer in a range of 1 to 20.

14. The ophthalmic device of claim 11 , wherein the mass:mass ratio of the fluorinated acrylate repeating unit to the silicon-containing repeating unit is in a range of about 2:1 to about 100:1.

15. The ophthalmic device of claim 11 , wherein the oil is selected from the group consisting of a hydrocarbon oil, a silicone oil, and a germane oil.

16. The ophthalmic device of claim 15 , wherein the lens material is configured to absorb less than 1 wt % of the oil after contacting an excess of the oil for 10 days at 37° C.

17. The ophthalmic device of claim 11 , wherein the lens material further encases in the enclosure a saline solution immiscible with the oil.

18. The ophthalmic device of claim 11 , further comprising a silicone hydrogel encasing the copolymer shaped to contact a corneal surface of an eye when the ophthalmic device is mounted to the eye.

Assignments (4)
CHANGE OF NAME Recorded Apr 1, 2026
From: VERILY LIFE SCIENCES LLC
To: VERILY HEALTH INC.
Reel/Frame 075367/0775 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2024
From: TWENTY TWENTY THERAPEUTICS LLC
To: VERILY LIFE SCIENCES LLC
Reel/Frame 068846/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2023
From: VERILY LIFE SCIENCES LLC
To: TWENTY TWENTY THERAPEUTICS LLC
Reel/Frame 064163/0186 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2020
From: DICICCIO, ANGELA; OTTS, DANIEL; KUIPER, STEIN
To: VERILY LIFE SCIENCES LLC
Reel/Frame 053934/0197 →
Continuity (2)
Provisional Application 62908451 · Sep 30, 2019
Related Publication 20210095063A1 · Apr 1, 2021